Project 8p Foundation hosts monthly Research Roundtables to share the latest advancements in 8p research, foster collaboration among researchers and medical professionals, and provide valuable updates for families in the 8p community.

As an open science organization, we are dedicated to making information accessible to everyone, empowering all to engage, learn, and contribute to our mission.

Contact kaiti@project8p.org to join.

Latest Research Roundtables

Phenotyping of mitochondrial dysfunction and DNA damage/repair in Chromosome 8p disorder

For our May 2022 Research Roundtable, we had Dr. Nicoleta Moisoi from De Montfort University, Leicester, UK discuss "Phenotyping of mitochondrial dysfunction and DNA damage/repair in Chromosome 8p disorder."

Artificial Intelligence (AI)-driven Drug Repurposing for Rare Disease

For our June 2022 Research Roundtable, Aleksandra Foksinska from Hugh Kaul Precision Medicine Institute at the University of Alabama at Birmingham presented “Artificial Intelligence (AI)-driven Drug Repurposing for Rare Disease”

The NDD-CNV Portal

For our July 2022 Research Roundtable, Dennis Lal, PhD presented the NDD-CNV Portal. If you’re interested in exploring the 8p data portal more, Click Here.

The Project 8p Foundation (Project 8p) was created in 2018 to:

  • Accelerate future treatments, not only for 8p, but potentially for other chromosome-wide diseases as well.
  • Lead with knowledge from patients. Currently, there is no cure for 8p disorders, nor is there a standard course of treatment.

The Project 8p Foundation (Project 8p) was created in 2018 to:

  • Raise transformative funding for pioneering scientific research into treatments for a complex, rare disease involving 250+ affected genes on the short arm of the 8 th chromosome (8p). Rearrangements of these genes causes significant abnormalities to the entire neurological system, thus all organs and functions of the body– with variance in cognitive functions, gross motor skills, social development and other challenges during infancy, and throughout life;
  • Empower a unified community of 8p patients and their families so they can have meaningful lives today; and
  • Accelerate future treatments, not only for 8p, but potentially for other chromosome-wide diseases as well.